| Literature DB >> 30276364 |
Tao Li1, Rong Hu1, Zi Chen1,2, Qiyuan Li3, Shouxiong Huang4, Zhou Zhu2, Lin-Fu Zhou1,5,6.
Abstract
Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased Fine particulate matter (PM2.5) concentrations cause elevated susceptibility to respiratory diseases, including acute respiratory distress, asthma, chronic obstructive pulmonary disease, and lung cancer. This review will discuss the pathophysiology of PM2.5 in respiratory diseases, which are helpful for the prevention of air pollution and treatment of respiratory tract inflammatory diseases.Entities:
Keywords: Air pollution; Chronic obstructive pulmonary disease; Lung diseases; Particulate matter
Year: 2018 PMID: 30276364 PMCID: PMC6160608 DOI: 10.1016/j.cdtm.2018.07.002
Source DB: PubMed Journal: Chronic Dis Transl Med ISSN: 2095-882X
Fig. 1Different size of particles deposit in the lung and other tissues. Large particles can be deposited in upper airways through sedimentation or impaction while in the lower airways. Brownian diffusion can deposit them in the alveoli. Ultrafine particles can translocate to blood circulation and be deposited in the liver, spleen, or brain, despite of penetrating through trans-synaptic mechanisms. PM: particulate matter.
Fig. 2Principal route of damage on human respiratory system after PM2.5 exposure. PM: particulate matter; VOC: volatile organic compounds; PAH: polycyclic aromatic hydrocarbon; ERK: extracellular regulated protein kinases; MAPK: mitogen-activated protein kinase; STAT-1: signal transducers and activators of transcription-1; COPD: chronic obstructive pulmonary disease.